The foundation, which is based in Madrid, awards Batlle for his research of excellence on colon cancer—one of the tumours with greatest prevalence worldwide.The foundation, which is based in Madrid, awards Batlle for his research of excellence on colon cancer—one of the tumours with greatest prevalence worldwide.
A study co-led by IRB Barcelona and IDIBAPS emphasizes the importance of the neuronal mechanisms in the detection of nutrients and the control of glucose levels.
The results published in Cell Metabolism help to understand diabetes in greater detail.
Researchers led by Salvador Aznar-Benitah at IRB Barcelona investigate the role of Dnmt3a and Dnmt3b proteins in skin homeostasis and tumour development in adult mice.
The study has been published in eLife and deserved an eLife digest aimed at a more general audience.
On May 27-28, the Barcelona Science Festival will bring a hundred science activities to the Parc de la Ciutadella.
IRB Barcelona is to participate in the Festival by giving a talk on Network Medicine and holding two workshops for a wide range of public.
During 2017, five activities programmed by the Institute to promote scientific culture will be supported by the FECYT.
Last Saturday IRB Barcelona held its Open Day and received around 400 visitors.
Public of all ages visited the labs, participated in workshops and attended talks at the centre, which is located at the Barcelona Science Park.
The renowned scientist joins the Institute for Research in Biomedicine (IRB Barcelona) after 13 years at CNIO, funded by the “la Caixa” Banking Foundation and by the Government of Catalonia's ICREA programme.
Manuel Serrano will study how damaged tissue is repaired and search for therapies based on regenerative medicine for the treatment of diabetes and other diseases.
From cancer to tissue repair, from CNIO to IRB Barcelona
The project, headed by group leader and ICREA researcher Eduard Batlle, receives a 60,000-€ grant.
The study will test the effectiveness of immunotherapies to treat metastatic disease in advanced colorectal cancer.
Research will take place during the academic years 2017 and 2018.
Prof. Joan J. Guinovart, founder-director of the Institute for Research in Biomedicine (IRB Barcelona) since October 2005, plans to step down from this position early in 2018.